We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4.36B
AUM Growth
+$1.18B
Cap. Flow
+$206M
Cap. Flow %
4.73%
Top 10 Hldgs %
59.63%
Holding
58
New
13
Increased
19
Reduced
21
Closed
2

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$59.8M
2
ELV icon
Elevance Health
ELV
+$56.6M
3
LYFT icon
Lyft
LYFT
+$50.4M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$41.3M
5
BAX icon
Baxter International
BAX
+$33.8M

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$67.3M
2
HCA icon
HCA Healthcare
HCA
+$49.5M
3
THC icon
Tenet Healthcare
THC
+$48.5M
4
HOLX
Hologic
HOLX
+$45.6M
5
MTOR
MERITOR, Inc.
MTOR
+$29.4M

Sector Composition

Rank Sector Weight
1 Healthcare 69.28%
2 Technology 11.97%
3 Materials 5.01%
4 Consumer Discretionary 4.95%
5 Industrials 3.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
26
DELISTED
Endo International plc
ENDP
$53.8M 1.23%
7,489,768
-1,224,716
-14% -$6.39M
PARA
27
DELISTED
Paramount Global Class B
PARA
$50M 1.15%
1,341,520
-2,098,305
-61% -$67.3M
CTVA icon
28
Corteva
CTVA
$51.3B
$49.9M 1.14%
1,289,420
-381,354
-23% -$13.6M
GOOGL icon
29
Alphabet (Google) Class A
GOOGL
$4.33T
$49.8M 1.14%
568,180
+491,280
+639% +$41.3M
BAX icon
30
Baxter International
BAX
$14.2B
$44.8M 1.03%
558,832
+426,209
+321% +$33.8M
CI icon
31
CALL
Cigna
CI
$74.6B
$41.6M 0.95%
+200,000
New +$39.2M
MOH icon
32
Molina Healthcare
MOH
$10.3B
$39.3M 0.9%
184,720
-23,654
-11% -$4.88M
MCK icon
33
CALL
McKesson
MCK
$101B
$34.8M 0.8%
+200,000
New +$33.3M
AMGN icon
34
Amgen
AMGN
$222B
$32.5M 0.75%
141,474
+96,171
+212% +$22.2M
DOC icon
35
Healthpeak Properties
DOC
$14.8B
$31.5M 0.72%
1,042,641
+635,713
+156% +$18.5M
MAR icon
36
Marriott International
MAR
$92.3B
$30.2M 0.69%
228,619
-209,098
-48% -$23.9M
MIK
37
DELISTED
Michaels Stores, Inc
MIK
$26M 0.6%
1,996,084
-257,415
-11% -$2.62M
NSC icon
38
Norfolk Southern
NSC
$75.1B
$22.6M 0.52%
+94,933
New +$21.6M
WELL icon
39
Welltower
WELL
$171B
$19.8M 0.45%
305,732
+181,693
+146% +$11M
DD icon
40
DuPont de Nemours
DD
$19.2B
$18.3M 0.42%
+205,542
New +$16.1M
DVA icon
41
DaVita
DVA
$11.7B
$16.5M 0.38%
140,613
-52,893
-27% -$5.39M
APTV icon
42
Aptiv
APTV
$10.3B
$14.4M 0.33%
+110,263
New +$12.2M
MDT icon
43
Medtronic
MDT
$112B
$13.3M 0.31%
113,882
– –
UNP icon
44
Union Pacific
UNP
$174B
$13.3M 0.3%
+63,731
New +$12.7M
NSP icon
45
Insperity
NSP
$2.01B
$13M 0.3%
+159,983
New +$13.1M
GPN icon
46
Global Payments
GPN
$22.8B
$13M 0.3%
+60,143
New +$11.2M
DGX icon
47
Quest Diagnostics
DGX
$26.3B
$12M 0.27%
100,567
-59,387
-37% -$7.24M
PRAH
48
DELISTED
PRA Health Sciences, Inc.
PRAH
$11.8M 0.27%
93,925
– –
PRSU
49
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
$9.08M 0.21%
250,995
+200,000
+392% +$5.45M
ARMK icon
50
Aramark
ARMK
$14.7B
$7.17M 0.16%
+258,243
New +$6.18M
1
2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return

Glenview Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Glenview Capital Management held 58 positions worth $4.36B, up 37% from $3.19B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Glenview Capital Management deployed $206M of net new capital in Q4 2020, opening 13 new positions and adding to 19 existing holdings. Its largest new stake was Elevance Health: 184,461 shares worth $59.2M.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 74% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Paramount Global Class B, an estimated $67.3M trimmed.

  • Glenview Capital Management's largest Q4 2020 buy was Elevance Health: 184,461 shares worth $59.2M.
  • Glenview Capital Management added most to Boston Scientific in Q4 2020, an estimated $59.8M increase.
  • Glenview Capital Management's biggest Q4 2020 reduction was Paramount Global Class B, cutting an estimated $67.3M.
  • Glenview Capital Management fully exited eBay in Q4 2020, selling an estimated $15.1M.
  • Glenview Capital Management's ten largest holdings make up 60% of its $4.36B portfolio in Q4 2020.
  • Glenview Capital Management opened 13 new positions and closed 2 in Q4 2020.
  • Glenview Capital Management's portfolio value rose 37% quarter-over-quarter to $4.36B.

Based on Glenview Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.